AT Bancorp’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-19,563
Closed -$1.25M 249
2018
Q4
$1.25M Buy
19,563
+539
+3% +$39.8K 0.17% 80
2018
Q3
$1.7M Sell
19,024
-4,598
-19% -$406K 0.18% 73
2018
Q2
$1.88M Sell
23,622
-5,604
-19% -$465K 0.21% 66
2018
Q1
$2.61M Buy
29,226
+2,845
+11% +$273K 0.28% 44
2017
Q4
$2.75M Buy
26,381
+4,144
+19% +$468K 0.3% 43
2017
Q3
$3.24M Buy
22,237
+16,679
+300% +$2.27M 0.37% 28
2017
Q2
$722K Sell
5,558
-4,366
-44% -$535K 0.08% 121
2017
Q1
$1.24M Sell
9,924
-4,424
-31% -$529K 0.16% 117
2016
Q4
$1.66M Sell
14,348
-278
-2% -$31K 0.22% 77
2016
Q3
$1.53M Buy
+14,626
New +$1.58M 0.21% 107
2016
Q2
Sell
-31,595
Closed -$3.16M 243
2016
Q1
$3.16M Buy
+31,595
New +$3.25M 0.48% 62
2015
Q3
Sell
-2,258
Closed -$262K 212
2015
Q2
$262K Sell
2,258
-8,226
-78% -$940K 0.07% 180
2015
Q1
$1.21M Sell
10,484
-813
-7% -$97.1K 0.33% 95
2014
Q4
$1.26M Buy
11,297
+1,107
+11% +$117K 0.38% 83
2014
Q3
$966K Sell
10,190
-30,306
-75% -$2.73M 0.28% 101
2014
Q2
$3.48M Buy
+40,496
New +$3.08M 1.04% 31

Other funds holding CELG

AT Bancorp's CELG Position: Q1 2019 in Review

AT Bancorp sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 19,563 shares — an estimated $1.25M sold.

AT Bancorp first reported a position in CELG in Q2 2014 and held it in 16 quarters. The position peaked at $3.48M in Q2 2014. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • AT Bancorp reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • AT Bancorp sold 19,563 Celgene Corp shares in Q1 2019, an estimated $1.25M.
  • AT Bancorp first reported a position in Celgene Corp in Q2 2014 and held it in 16 quarters.
  • AT Bancorp's Celgene Corp position peaked at $3.48M in Q2 2014.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.